MDNAF SEC Comment Letters | Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp. SEC Comment Letters

No SEC Comment Letters for MDNAF on this site yet.

Source checked: its SEC EDGAR filings (CIK 1807983).